Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative Group. Academic Article uri icon

Overview

publication date

  • May 1, 1989

Research

keywords

  • Alkaloids
  • Antineoplastic Agents
  • Carcinoma
  • Ellipticines
  • Lung Neoplasms

Identity

Scopus Document Identifier

  • 0024408868

PubMed ID

  • 2737223

Additional Document Info

volume

  • 25

issue

  • 5